26 October 2017 in Infectious Diseases
There is a number of publications evaluating the eosinophil count and the neutrophil-to-lymphocyte count ratio for diagnosis, prognosis or monitoring of patients. Of special interest is the use of these parameters for discrimination between the different causes of fever (e.g. bacterial versus viral vs. non-infectious causes of fever) and for monitoring the efficacy of therapy and predict the course of the patient. However, pitfalls in previous study designs prevent applicability to clinical practice. Here, we provide a short review of the relevant literature and summarize important factors that should be taken into account when designing studies, with special attention to the selection of a proper and clinically meaningful study population and the effects of the stress response and of corticosteroids.
11 November 2017 in Infection
6 March 2018 in Infectious Diseases
Purpose: The practice of obtaining blood culture in febrile urinary tract infections is controversial, considering that blood cultures rarely provide additional useful information compared to urine cultures alone. Furthermore, whether a longer treatment duration is necessary in bacteremic patients is also controversial. Here, we aim to review to relevant studies. Materials and methods: We searched PubMed and Scopus for studies providing information regarding the discordance between urine and blood cultures. We also searched for clinical trials regarding the treatment duration in bacteremic patients with urinary tract infections. Results: It seems that a higher likelihood of a negative urine culture (e.g. in patients with antibiotic pre-treatment) combined with a higher likelihood of a positive blood culture (e.g. patients with high fever, or patients with complicated urinary tract infections) increases the chance that a blood culture might provide additional useful information. Furthermore, when polymicrobial infection or contamination of the urine specimen is likely (e.g. in patients with indwelling urinary tract catheters or bedridden patients with frequent hospitalizations and catheterizations), blood cultures may help identify the clinically significant pathogen and guide the choice of the antimicrobial regimen. Finally, because bacteremia has been associated with more severe disease and worse outcomes, some authors suggest a longer treatment duration for bacteremic patients. However, whether the presence of bacteremia should alter the duration of treatment remains unclear. Conclusions: Obtaining blood cultures may be useful in selected patients. Randomized controlled trials are needed to clarify the value of bacteremia in guiding the duration of antimicrobial therapy.
10 November 2017 in Expert Review of Gastroenterology & Hepatology
Introduction: The usefulness of nasogastric aspiration and nasogastric lavage in patients with gastrointestinal bleeding is controversial, as evidenced by conflicting recommendations, both among and within society guidelines. Areas covered: Considering these controversies, we reviewed the evidence regarding the following questions: 1) Can nasogastric lavage stop or slow down the bleeding and improve subsequent endoscopic visualization? 2) Is nasogastric aspiration helpful for the localization of bleeding? 3) Can nasogastric aspiration identify high risk patients that might benefit from earlier endoscopy? 4) Is there evidence for benefit in terms of outcomes from using nasogastric aspiration? 5) Is nasogastric intubation safe in patients with possible esophageal varices? Our review was conducted according to PRISMA guidelines. Expert commentary: Based on the available literature, nasogastric lavage or aspiration cannot be routinely recommended unless a large properly designed randomized trial (which is currently lacking) proves otherwise. It is a painful and time-consuming procedure with no demonstrated benefit for the patient in terms of outcomes. Other clinical and laboratory parameters, and risk scores, are less invasive and are effective for guiding the stratification and management of patients, while pre-endoscopic erythromycin infusion is a good if not better alternative for improving visualization of the stomach.
28 February 2018 in Infectious Diseases
Background: Staphylococcus aureus bacteriuria (SABU) concomitant to S. aureus bacteremia (SAB) has been associated with deep-seated infections and worse prognosis. However, the relevant studies were small and inconsistent. Here, we aim to provide a review of the relevant literature, and a meta-analysis of these studies. Methods: We searched PubMed and Scopus for studies comparing patients with SAB and concomitant SABU to patients with SAB without SABU. Results: Nine relevant studies were identified, involving 1429 patients with SAB, of whom 18.5% (n = 265) had concomitant SABU. Pooling the results of those studies, SABU was significantly associated with endocarditis, bone/joint infection and septic embolism. SABU was also associated with persistent SAB, and higher mortality. Conclusions: Although SABU may be a useful marker of complicated SAB, the current literature has several limitations. Larger prospective studies are required to clarify the value of SABU in clinical decision making.
20 November 2017 in Journal of the American Geriatrics Society
See the Reply by Cataudella et al.